Elanco Animal Health Inc. has entered into Amendment No. 3 to its existing Credit Agreement, originally dated August 1, 2020. The amendment, completed on October 31, 2025, involves a consortium of lenders and financial institutions including JPMorgan Chase Bank, N.A., Wilmington Trust, and others. Under the revised terms, Elanco secured new U.S. dollar-denominated term loans totaling $1.1 billion with a maturity date of October 31, 2032, a new tranche of €400 million euro-denominated senior secured term loans maturing April 30, 2029, and $540 million in farm credit term loans also maturing October 31, 2032. The proceeds, combined with company cash, were used to refinance all outstanding borrowings under Elanco's previous term loan B facility due 2027 and to pay related fees and expenses. The amendment also introduced various changes to the covenants and terms of the original Credit Agreement.